Where and how can I find the best cancer treatments?

As a cancer patient, you may have a lot of questions. It is not always possible to get answers from doctors or oncologists. We provide data-driven answers to cancer patients so that they can decide what is the best cancer treatment option out there. We believe that with proper information patients can advocate for themselves and make informed decisions together with their doctors. We simplify cancer therapies for patients. We have helped hundreds of patients understand their options and make educated decisions. We provide you data from the same source that the healthcare professionals use. To understand the FDA-approved treatment options read our PRIORITY REPORTS on individual cancers. If you have a specific cancer treatment related question, we can provide an ADVANCED REPORT. If you want to learn about cancer and treatments in details and understand options from a cancer coach, we can provide DIRECT CONSULTATION as well.


There are several factors that will determine whether immunotherapy is going to work for you or not. The PD-L1 expression levels, as determined by an FDA-approved companion diagnostic test, are important for anti PD-L1 antibodies, such as pembrolizumab (brand name KEYTRUDA from Merck). Sometimes the side effects can be limiting and therefore the immunotherapy may not be continued. There are certain unknown variable as well, such as the tumor microenvironment and how that modulates the immune response. That is why every patient is unique and each outcome can vary. We can help you using bioinformatics and by analyzing the outcomes data of thousands of patients available form public data sets. The results are great indicators of how things are going to go. For information research with your unique diagnosis, email tellus@cancertherapies4u.com. To learn about all the FDA-approved immunotherapy for a particular cancer type, read our PRIORITY REPORT on that particular type of cancer. 


Chemotherapy may have a lot of temporary painful side effects, but it has been successful in improving lifespan for millions of cancer patients. The future of cancer treatment is moving towards immunotherapy combined with chemotherapy. As cancer management has improved, the mortality rate from cancer has dropped by 25% in the past 25 years. An efficient alternative to cytotoxic chemotherapy would be targeted therapy, where a mutant kinase protein is targeted given that the cancer has a mutated kinase. These treatments are called targeted treatments.  


By using bioinformatics to analyze large scale patient data, we can bring you the answers to any cancer treatment related questions that you have. With our data-driven approach you can be confident that you are making informed decisions. There is so much information out there that it can be really confusing. It matters where you get your scientific information from. 


  • Facebook
  • Twitter

©2021 by CancerTherapies4U LLC     All rights reserved.